Guilherme Lopes Yamamoto1, Meire Aguena2, Monika Gos3, Christina Hung4, Jacek Pilch5, Somayyeh Fahiminiya6, Anna Abramowicz3, Ingrid Cristian7, Michelle Buscarilli8, Michel Satya Naslavsky2, Alexsandra C Malaquias9, Mayana Zatz2, Olaf Bodamer4, Jacek Majewski6, Alexander A L Jorge9, Alexandre C Pereira10, Chong Ae Kim8, Maria Rita Passos-Bueno2, Débora Romeo Bertola1. 1. Unidade de Genética, Instituto da Criança, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil Centro de Pesquisa sobre o Genoma Humano e Células-Tronco, Instituto de Biociências da Universidade de São Paulo, São Paulo, São Paulo, Brazil. 2. Centro de Pesquisa sobre o Genoma Humano e Células-Tronco, Instituto de Biociências da Universidade de São Paulo, São Paulo, São Paulo, Brazil. 3. Department of Medical Genetics, Institute of Mother and Child, Warsaw, Poland. 4. Division of Genetics and Genomics, Department of Medicine, Boston Children's Hospital, Boston, Massachusetts, USA. 5. Department of Child Neurology, Medical University of Silesia, Katowice, Poland. 6. Department of Human Genetics, McGill University, Montreal, Quebec, Canada. 7. Nemours Children's Hospital Orlando, Orlando, Florida, USA. 8. Unidade de Genética, Instituto da Criança, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil. 9. Departamento de Endocrinologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil. 10. Instituto de Cardiologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, São Paulo, Brazil.
Abstract
BACKGROUND: Noonan syndrome is an autosomal dominant, multisystemic disorder caused by dysregulation of the RAS/mitogen activated protein kinase (MAPK) pathway. Heterozygous, pathogenic variants in 11 known genes account for approximately 80% of cases. The identification of novel genes associated with Noonan syndrome has become increasingly challenging, since they might be responsible for very small fractions of the cases. METHODS: A cohort of 50 Brazilian probands negative for pathogenic variants in the known genes associated with Noonan syndrome was tested through whole-exome sequencing along with the relatives in the familial cases. Families from the USA and Poland with mutations in the newly identified genes were included subsequently. RESULTS: We identified rare, segregating or de novo missense variants in SOS2 and LZTR1 in 4% and 8%, respectively, of the 50 Brazilian probands. SOS2 and LZTR1 variants were also found to segregate in one American and one Polish family. Notably, SOS2 variants were identified in patients with marked ectodermal involvement, similar to patients with SOS1 mutations. CONCLUSIONS: We identified two novel genes, SOS2 and LZTR1, associated with Noonan syndrome, thereby expanding the molecular spectrum of RASopathies. Mutations in these genes are responsible for approximately 3% of all patients with Noonan syndrome. While SOS2 is a natural candidate, because of its homology with SOS1, the functional role of LZTR1 in the RAS/MAPK pathway is not known, and it could not have been identified without the large pedigrees. Additional functional studies are needed to elucidate the role of LZTR1 in RAS/MAPK signalling and in the pathogenesis of Noonan syndrome. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
BACKGROUND:Noonan syndrome is an autosomal dominant, multisystemic disorder caused by dysregulation of the RAS/mitogen activated protein kinase (MAPK) pathway. Heterozygous, pathogenic variants in 11 known genes account for approximately 80% of cases. The identification of novel genes associated with Noonan syndrome has become increasingly challenging, since they might be responsible for very small fractions of the cases. METHODS: A cohort of 50 Brazilian probands negative for pathogenic variants in the known genes associated with Noonan syndrome was tested through whole-exome sequencing along with the relatives in the familial cases. Families from the USA and Poland with mutations in the newly identified genes were included subsequently. RESULTS: We identified rare, segregating or de novo missense variants in SOS2 and LZTR1 in 4% and 8%, respectively, of the 50 Brazilian probands. SOS2 and LZTR1 variants were also found to segregate in one American and one Polish family. Notably, SOS2 variants were identified in patients with marked ectodermal involvement, similar to patients with SOS1 mutations. CONCLUSIONS: We identified two novel genes, SOS2 and LZTR1, associated with Noonan syndrome, thereby expanding the molecular spectrum of RASopathies. Mutations in these genes are responsible for approximately 3% of all patients with Noonan syndrome. While SOS2 is a natural candidate, because of its homology with SOS1, the functional role of LZTR1 in the RAS/MAPK pathway is not known, and it could not have been identified without the large pedigrees. Additional functional studies are needed to elucidate the role of LZTR1 in RAS/MAPK signalling and in the pathogenesis of Noonan syndrome. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Yline Capri; Elisabetta Flex; Oliver H F Krumbach; Giovanna Carpentieri; Serena Cecchetti; Christina Lißewski; Soheila Rezaei Adariani; Denny Schanze; Julia Brinkmann; Juliette Piard; Francesca Pantaleoni; Francesca R Lepri; Elaine Suk-Ying Goh; Karen Chong; Elliot Stieglitz; Julia Meyer; Alma Kuechler; Nuria C Bramswig; Stephanie Sacharow; Marion Strullu; Yoann Vial; Cédric Vignal; George Kensah; Goran Cuturilo; Neda S Kazemein Jasemi; Radovan Dvorsky; Kristin G Monaghan; Lisa M Vincent; Hélène Cavé; Alain Verloes; Mohammad R Ahmadian; Marco Tartaglia; Martin Zenker Journal: Am J Hum Genet Date: 2019-05-23 Impact factor: 11.025
Authors: Man Li; Yong Li; Olivia Weeks; Vladan Mijatovic; Alexander Teumer; Jennifer E Huffman; Gerard Tromp; Christian Fuchsberger; Mathias Gorski; Leo-Pekka Lyytikäinen; Teresa Nutile; Sanaz Sedaghat; Rossella Sorice; Adrienne Tin; Qiong Yang; Tarunveer S Ahluwalia; Dan E Arking; Nathan A Bihlmeyer; Carsten A Böger; Robert J Carroll; Daniel I Chasman; Marilyn C Cornelis; Abbas Dehghan; Jessica D Faul; Mary F Feitosa; Giovanni Gambaro; Paolo Gasparini; Franco Giulianini; Iris Heid; Jinyan Huang; Medea Imboden; Anne U Jackson; Janina Jeff; Min A Jhun; Ronit Katz; Annette Kifley; Tuomas O Kilpeläinen; Ashish Kumar; Markku Laakso; Ruifang Li-Gao; Kurt Lohman; Yingchang Lu; Reedik Mägi; Giovanni Malerba; Evelin Mihailov; Karen L Mohlke; Dennis O Mook-Kanamori; Antonietta Robino; Douglas Ruderfer; Erika Salvi; Ursula M Schick; Christina-Alexandra Schulz; Albert V Smith; Jennifer A Smith; Michela Traglia; Laura M Yerges-Armstrong; Wei Zhao; Mark O Goodarzi; Aldi T Kraja; Chunyu Liu; Jennifer Wessel; Eric Boerwinkle; Ingrid B Borecki; Jette Bork-Jensen; Erwin P Bottinger; Daniele Braga; Ivan Brandslund; Jennifer A Brody; Archie Campbell; David J Carey; Cramer Christensen; Josef Coresh; Errol Crook; Gary C Curhan; Daniele Cusi; Ian H de Boer; Aiko P J de Vries; Joshua C Denny; Olivier Devuyst; Albert W Dreisbach; Karlhans Endlich; Tõnu Esko; Oscar H Franco; Tibor Fulop; Glenn S Gerhard; Charlotte Glümer; Omri Gottesman; Niels Grarup; Vilmundur Gudnason; Torben Hansen; Tamara B Harris; Caroline Hayward; Lynne Hocking; Albert Hofman; Frank B Hu; Lise Lotte N Husemoen; Rebecca D Jackson; Torben Jørgensen; Marit E Jørgensen; Mika Kähönen; Sharon L R Kardia; Wolfgang König; Charles Kooperberg; Jennifer Kriebel; Lenore J Launer; Torsten Lauritzen; Terho Lehtimäki; Daniel Levy; Pamela Linksted; Allan Linneberg; Yongmei Liu; Ruth J F Loos; Antonio Lupo; Christine Meisinger; Olle Melander; Andres Metspalu; Paul Mitchell; Matthias Nauck; Peter Nürnberg; Marju Orho-Melander; Afshin Parsa; Oluf Pedersen; Annette Peters; Ulrike Peters; Ozren Polasek; David Porteous; Nicole M Probst-Hensch; Bruce M Psaty; Lu Qi; Olli T Raitakari; Alex P Reiner; Rainer Rettig; Paul M Ridker; Fernando Rivadeneira; Jacques E Rossouw; Frank Schmidt; David Siscovick; Nicole Soranzo; Konstantin Strauch; Daniela Toniolo; Stephen T Turner; André G Uitterlinden; Sheila Ulivi; Dinesh Velayutham; Uwe Völker; Henry Völzke; Melanie Waldenberger; Jie Jin Wang; David R Weir; Daniel Witte; Helena Kuivaniemi; Caroline S Fox; Nora Franceschini; Wolfram Goessling; Anna Köttgen; Audrey Y Chu Journal: J Am Soc Nephrol Date: 2016-12-05 Impact factor: 10.121
Authors: Andrew R Grant; Brandon J Cushman; Hélène Cavé; Mitchell W Dillon; Bruce D Gelb; Karen W Gripp; Jennifer A Lee; Heather Mason-Suares; Katherine A Rauen; Marco Tartaglia; Lisa M Vincent; Martin Zenker Journal: Hum Mutat Date: 2018-11 Impact factor: 4.878
Authors: Johannes W Bigenzahn; Giovanna M Collu; Felix Kartnig; Melanie Pieraks; Gregory I Vladimer; Leonhard X Heinz; Vitaly Sedlyarov; Fiorella Schischlik; Astrid Fauster; Manuele Rebsamen; Katja Parapatics; Vincent A Blomen; André C Müller; Georg E Winter; Robert Kralovics; Thijn R Brummelkamp; Marek Mlodzik; Giulio Superti-Furga Journal: Science Date: 2018-11-15 Impact factor: 47.728
Authors: Simone Martinelli; Oliver H F Krumbach; Francesca Pantaleoni; Simona Coppola; Ehsan Amin; Luca Pannone; Kazem Nouri; Luciapia Farina; Radovan Dvorsky; Francesca Lepri; Marcel Buchholzer; Raphael Konopatzki; Laurence Walsh; Katelyn Payne; Mary Ella Pierpont; Samantha Schrier Vergano; Katherine G Langley; Douglas Larsen; Kelly D Farwell; Sha Tang; Cameron Mroske; Ivan Gallotta; Elia Di Schiavi; Matteo Della Monica; Licia Lugli; Cesare Rossi; Marco Seri; Guido Cocchi; Lindsay Henderson; Berivan Baskin; Mariëlle Alders; Roberto Mendoza-Londono; Lucie Dupuis; Deborah A Nickerson; Jessica X Chong; Naomi Meeks; Kathleen Brown; Tahnee Causey; Megan T Cho; Stephanie Demuth; Maria Cristina Digilio; Bruce D Gelb; Michael J Bamshad; Martin Zenker; Mohammad Reza Ahmadian; Raoul C Hennekam; Marco Tartaglia; Ghayda M Mirzaa Journal: Am J Hum Genet Date: 2018-01-25 Impact factor: 11.025